ANGEL GUERRA TORRES: Open Payments
NPI 1750422671 · MAYAGUEZ, PR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 10 payments from 6 companies in 2025. Trend: 2023 $169 · 2024 $254 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $329 |
| Janssen Pharmaceuticals, Inc | 3 | $265 |
| ABBVIE INC. | 1 | $125 |
| ACADIA Pharmaceuticals Inc | 1 | $70 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $23 |
Products named: COBENFY, INVEGA SUSTENNA, VRAYLAR, NUPLAZID, SYMTUZA, DELSTRIGO, Biktarvy.
Industry payments across PR — which companies pay providers there.
